SCHEMBL28043754

SCHEMBL28043754

NCc1ccc(Cl)cc1-c1cc(Cl)nc(N)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 11/20 0.62
HSP90AA1 P07900 10/20 0.62
KDM4E B2RXH2 1/20 0.46
ADCY10 Q96PN6 2/20 0.45
AGPAT2 O15120 4/20 0.43
HTR2B P41595 1/20 0.42
PDE4D Q08499 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CDC7 O00311 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
PIM1 P11309 1/20 0.41
PRKACA P17612 1/20 0.41
GRK5 P34947 1/20 0.41
MAP2K2 P36507 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK8 P49336 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4282276 0.86 HSP90AB1 (0.60) HSP90AB1HSP90AA1KDM4EADCY10AGPAT2
SCHEMBL28043958 0.81 NUDT1 (0.54) AGPAT2
SCHEMBL4281889 0.80 HSP90AB1 (0.75) HSP90AB1HSP90AA1KDM4EAGPAT2HTR2B
SCHEMBL28043963 0.79 AGPAT2 (0.51) KDM4EAGPAT2SMN1; SMN2CDK9CDK5
SCHEMBL28043877 0.78 HSP90AA1 (0.59) HSP90AB1HSP90AA1KDM4EADCY10CDC7
SCHEMBL4282884 0.78 AGPAT2 (0.67) HSP90AB1HSP90AA1KDM4EAGPAT2
SCHEMBL4291570 0.78 HSP90AA1 (0.66) HSP90AB1HSP90AA1KDM4EAGPAT2HTR2B
SCHEMBL28043753 0.77 NUDT1 (0.58) AGPAT2ROCK1
SCHEMBL3944846 0.77 HSP90AB1 (1.00) HSP90AB1HSP90AA1KDM4EAGPAT2HTR2B
SCHEMBL28267174 0.76 CDC7 (0.38) HSP90AB1HSP90AA1CDC7DAPK3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed